St. Louis-born Galera Therapeutics goes public with $60M IPO

//St. Louis-born Galera Therapeutics goes public with $60M IPO

St. Louis-born Galera Therapeutics goes public with $60M IPO

Galera Therapeutics, a Pennsylvania-based biotechnology startup that has its research and development segment in St. Louis, has raised $60 million in an initial public offering. The company, which is developing treatments to reduce the harmful effect of radiation therapy, raised the $60 million by selling 5 million shares of its common stock at $12 per share per share. In documents filed with the Securities and Exchange Commission last week, Galera said it expected to sell its shares at between…

Article by [author-name] (c) Technology News - Technology News Headlines | Bizjournals.com - Read full story here.

By | 2019-11-07T20:09:39+00:00 November 7th, 2019|Technology|

About the Author: